Clinical Trials Logo

Chorioamnionitis clinical trials

View clinical trials related to Chorioamnionitis.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT04651309 Completed - Pregnancy Related Clinical Trials

Assessment of Labour Progress by Intrapartum Ultrasound

Start date: August 27, 2019
Phase: N/A
Study type: Interventional

Assessment of labor progress via digital exams is considered the standard of care in most delivery rooms. However, this method can be stressful, painful and imprecise and multiple exams increase the risk for chorioamnionitis. Trans-perineal ultrasound (TPUS) was found to be an objective noninvasive way to monitor labor progress. The study aim is to investigate whether, in nulliparous women, the use of TPUS during labor can reduce the number of vaginal exams and the incidence of chorioamnionitis.

NCT ID: NCT04513691 Completed - Clinical trials for Early-Onset Sepses, Neonatal

A Chart Review of Newborns With the Presence of Confirmed or Suspected Maternal Chorioamnionitis and Utilization of the Early Onset Sepsis Calculator

Start date: September 30, 2020
Phase:
Study type: Observational

This study will review practices in relation to chorioamnionitis (CAM) before and after to the implementation of the Neonatal Early-Onset Sepsis (EOS) Risk Calculator to determine the effect in the nursery at Banner - University Medical Center Phoenix. Newborns enrolled will be at least 35 weeks gestational age (GA) and have a maternal diagnosis of at least suspected or confirmed CAM. The data will include those newborns whose assessment and treatment were not guided by the EOS calculator which was implemented on August 28, 2019 and those with which the EOS calculator was utilized. A secondary objective is to show the economic impact with utilization of the EOS calculator. Data collected will include full laboratory workups including complete blood counts (CBC), blood cultures, antibiotic usage, length of time in the newborn nursery and total length of stay.

NCT ID: NCT03636698 Completed - Thrombocytopenia Clinical Trials

Effect of Chorioamnionitis on Platelet Activation and Placental Vessel Among Preterm Infants by Wnt-Flt1 Signal Pathway

Start date: June 1, 2016
Phase:
Study type: Observational

Objective:The purpose of this study was to explore the effect and mechanism of maternal chorioamnionitis on placental microvasculature and platelet activation among preterm infants by activating Wnt-Flt1 signal pathway . Methods:With clinical randomized controlled trial (RCT), the cases were matched with 1:1 according to gestational age and divided into 2 groups according to the placental pathology result: chorioamnionitis group and control group. (1) To observe the platelet parameter, birth weight, thrombrocytopenia and hemorrhage complication, such as intracranial hemorrhage, retinal hemorrhage, pulmonary hemorrhage and gastrointestinal hemorrhage. (2) To observe the miscrovascular density (MVD) in placenta, platelet activating factor (CD62p,CD63) and thrombopotetin (TPO) in preterrn infants.The placental MVD was assessed by immunohistochemical method. The platelet activating factors were detected by flow cytometry. TPO was detected by ELISA. (3) To observe Wnt5a, Flt1 and VEGF in placenta and fetal circulation.The measurement data were analyzed by pair t test and conditional logistic regression. Pearson correlation analysis was used for relationship.

NCT ID: NCT03576560 Completed - Chorioamnionitis Clinical Trials

Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis

Chorio
Start date: June 26, 2017
Phase:
Study type: Observational

Retrospective Chart Review to determine the selective use of antibiotics in neonates born to mothers with suspected chorioamnionitis

NCT ID: NCT02996279 Completed - Clinical trials for Chorioamnionitis Affecting Fetus or Newborn

Chorioamnionitis and Proinflammatory S100A12

S100A12
Start date: February 2012
Phase: N/A
Study type: Observational

Histologic chorioamnionitis (HCA) may lead to the fetal inflammatory response syndrome (FIRS) and increased levels of proinflammatory molecules.

NCT ID: NCT02901795 Completed - Clinical trials for Fetal Membranes, Premature Rupture

Early Detection of Chorioamnionitis in Preterm Premature Rupture of Membranes

AiRPM
Start date: November 2, 2018
Phase:
Study type: Observational

All included patients will have their fetal heart rate recording performed with an EDAN F3 fetal monitor that allowed the back up recording of the fetal heart rate beat to beat detection. Fetal heart rate variability analysis will be performed using Matalb® software.

NCT ID: NCT02702297 Completed - Clinical trials for Preterm Premature Rupture of Membranes

Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes

MuMFI-PPROM
Start date: January 7, 2016
Phase:
Study type: Observational

The purpose of this study is to examine whether the value of vaginal fluid cytokine levels as well as computerized fetal ECG analysis are suitable clinical parameters to detect an imminent intra-amniotic inflammation with a high risk of fetal inflammatory response syndrome (FIRS) or a neonatal early onset sepsis (EOS) and whether these parameters can be determined on a daily basis in the clinical monitoring of pregnancies complicated by PPROM.

NCT ID: NCT01852188 Completed - Chorioamnionitis Clinical Trials

Intrapartum Study of Sterile and Clean Gloves

Start date: May 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the use of sterile or clean gloves during labor exams affects the rate of chorioamnionitis. Chorioamnionitis is an infection of the membranes around the baby.

NCT ID: NCT01633294 Completed - Chorioamnionitis Clinical Trials

Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term

Start date: October 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The aims of this study are to determine whether antibiotics administered routinely in women presenting with premature rupture of membranes later than the 37+0 weeks of gestation can alter the rate of maternal and neonatal infection and to compare these rates between prompt (< 12 hour) and delayed (≥ 12 hour) induction in the group of patients not submitted to antibiotic prophylaxis.

NCT ID: NCT01610258 Completed - Clinical trials for Pathology of Pregnancy

Maternal Plasmatic Regulatory T Cells and Th17 as Possible Diagnosis Markers of Acute Chorioamnionitis

ICAR
Start date: March 26, 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if regulator T cells (Treg) and Th17 level modifications in maternal blood and placenta could be correlated to a chorioamnionitis, in women hospitalized for PPROM.